Turn Therapeutics Inc. (TTRX) reporting calendar
Turn Therapeutics Inc. files periodic reports with the SEC as TTRX on Nasdaq. Atlas tracks 3 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 11 May 2026
- Reports on record
- 3
Open TTRX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 11 May 2026 | 41 days | 0001213900-26-054490 |
| 10-K | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001213900-26-037505 |
| 10-Q | 30 Sep 2025 | 13 Nov 2025 | 44 days | 0001213900-25-109586 |
Source: SEC EDGAR company submissions for CIK 0002023016. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.